Financhill
Buy
53

IMDX Quote, Financials, Valuation and Earnings

Last price:
$5.81
Seasonality move :
20.46%
Day range:
$5.31 - $5.56
52-week range:
$1.92 - $8.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
32.92x
P/B ratio:
196.14x
Volume:
24.4K
Avg. volume:
69K
1-year change:
153.88%
Market cap:
$155.1M
Revenue:
$1.9M
EPS (TTM):
-$2.83

Earnings Data

Next earnings date for IMDX
Mar 24
2026
Most recent earnings per share
-$0.34
Missed by $0.10
(Nov 10/2025)
Consensus Estimate
-$0.24
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMDX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 $285K -- -- -$0.23 --
11/10/2025 Q3 $285K $260K -$0.34 -$0.24 -$0.10
08/11/2025 Q2 $292K $518K -$0.30 -$0.24 -$0.06
05/14/2025 Q1 $126.8K $2.1M -$0.26 -$0.25 -$0.01
12/31/2024 Q4 $101.7K $1.5M -$1.93 -- --
09/30/2024 Q3 $168.3K $115K -$0.98 -- --
06/30/2024 Q2 $312.4K $104K -$0.36 -$0.37 $0.01
03/31/2024 Q1 $350K $176K -$1.13 -$0.57 -$0.56
12/31/2023 Q4 $316.7K $314K -$1.94 -- --
09/30/2023 Q3 -- $429K -$0.81 -- --
06/30/2023 Q2 -- $463K -$21.37 -- --
03/31/2023 Q1 -- $297K $0.40 -- --
12/31/2022 Q4 -- $274K -$8.03 -- --
09/30/2022 Q3 -- $67K -$1.62 -- --
06/30/2022 Q2 -- $237K -$1.48 -- --
03/31/2022 Q1 -- $380K -$2.23 -- --
12/31/2021 Q4 -- $3.6M -$7.78 -- --
09/30/2021 Q3 -- $984K -$3.02 -- --
06/30/2021 Q2 -- $2M -$2.34 -- --
03/31/2021 Q1 -- $1.1M -$0.95 -- --
12/31/2020 Q4 -- $503K -$1.87 -- --
09/30/2020 Q3 -- $555K -$2.02 -- --
06/30/2020 Q2 -- $143K -$2.77 -- --
03/31/2020 Q1 -- $16K -$2.52 -- --
12/31/2019 Q4 -- -- -$2.92 -- --
09/30/2019 Q3 -- -- -$2.01 -- --
06/30/2019 Q2 -- -- -$2.07 -- --
03/31/2019 Q1 -- -- -$1.66 -- --
12/31/2018 Q4 -- -- -$2.21 -- --
09/30/2018 Q3 -- -- -$1.48 -- --
06/30/2018 Q2 -- -- -$2.33 -- --
03/31/2018 Q1 -- -- -$2.39 -- --
12/31/2017 Q4 -- -- -$2.60 -- --
09/30/2017 Q3 -- -- -$4.40 -- --
06/30/2017 Q2 -- -- -$2.60 -- --
03/31/2017 Q1 -- -- -$3.20 -- --
12/31/2016 Q4 -- -- -$2.20 -- --
09/30/2016 Q3 -- -- -$2.00 -- --
06/30/2016 Q2 -- -- -$2.00 -- --
03/31/2016 Q1 -- -- -$2.40 -- --
12/31/2015 Q4 -- -- -$2.80 -- --

Insight Molecular Diagnostics, Inc. Earnings Questions

  • How Much did Insight Molecular Diagnostics, Inc. Generate in Revenue Last Quarter?

    Insight Molecular Diagnostics, Inc. reported $260K worth of top line sales in its most recent quarter.

  • Did Insight Molecular Diagnostics, Inc. Beat Earnings Last Quarter?

    Insight Molecular Diagnostics, Inc. announced earnings per share of -$0.34 which represents a miss of analyst forecast a -$0.24 per share.

  • Is Insight Molecular Diagnostics, Inc. Profitable?

    Insight Molecular Diagnostics, Inc. reported -$423K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Insight Molecular Diagnostics, Inc. EPS Next Year?

    Insight Molecular Diagnostics, Inc.'s earnings are forecast to decrease from -$4.66 per share to -$1.03 per share next year representing a decrease of -77.9%.

  • When is Insight Molecular Diagnostics, Inc.'s Earnings Date?

    Insight Molecular Diagnostics, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock